R&D share of pharmaceutical direct economic contribution

Percentage of the pharmaceutical sector's direct gross economic contribution accounted for by research and development activities.

Unit Percent Industry Pharmaceuticals

Records
1
Regions
1
Period
2022
Sources
1
Verification 1 verified data points Updated 17 Sep 2026 Last verified 17 Sep 2026 Next update Sources typically refresh annually

The chart

The figure

One published observation so far. A chart follows as soon as a second period is published.

R&D share of pharmaceutical direct economic contribution

Global, 2022

1 observation
30% Global · 2022 · IFPMA · full record
Source: IFPMA · CC BY 4.0 · statorigin.org

Every record

All records

1 record · 1 region · 2022

R&D share of pharmaceutical direct economic contribution: every record, grouped by region, newest first.
Period Value Source Type
Global 1 record
2022 30% IFPMA · 31 Dec 2022 actual

Primary documents

Sources

1 document. Each links to the publisher's own copy.

Document Publisher Published Data points
Enabling innovation: The R&D ecosystem for medicines and vaccines IFPMA 1

Cite & reuse

Cite this page

Data on this page is published under CC BY 4.0. You may reuse it, including commercially, provided you attribute it. To cite one figure, open its record: each carries APA, MLA, Chicago and BibTeX forms that credit the original publisher.

StatOrigin. (2026). R&D share of pharmaceutical direct economic contribution. Retrieved from https://statorigin.org/indicators/r-d-share-of-pharmaceutical-direct-economic-contribution